Q1 2026 · 13F-HR
Knoll Capital Management, LLCholdings as filed
Filed 2026-05-15 · accession 0001104659-26-062445
$180.2M
Reported value
37
Positions
2026-03-31
Period end
The Brief · Knoll Capital Management, LLC · Q1 2026
AI · grounded in 13F
Knoll Capital Management, LLC exited its position in Avadel Pharmaceuticals Plc, a move totaling $12.93M. The fund also closed its holdings in GLD for $12.68M and SLV for $5.15M. To offset these exits, the manager established new positions in PHYS for $13.72M and PSLV for $5.42M. Additionally, the fund increased its stake in TFPM by 95.58% and FNV by 28%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G11196105 | — | Biohaven Pharmactl Hldg Co | $19.7M | 10.9% | 2,328,602 | Common | SOLE |
| 85207H104 | PHYS | Sprott physical gold Trust | $13.7M | 7.61% | 387,055 | Common | SOLE |
| 780287108 | RGLD | Royal Gold Inc. | $13.4M | 7.45% | 52,750 | Common | SOLE |
| G59665102 | MGTX | MeiraGTX Holdings | $10.8M | 6.01% | 1,250,000 | Common | SOLE |
| 008474108 | AEM | Agnico Eagle Mines Ltd | $10.7M | 5.94% | 52,750 | Common | SOLE |
| 496902404 | KGC | Kinross Gold Corp | $9.8M | 5.42% | 320,000 | Common | SOLE |
| 01438T106 | ALDX | Aldeyra Therapeutics Inc | $9.3M | 5.14% | 5,475,516 | Common | SOLE |
| 811916105 | SA | SEABRIDGE GOLD INC | $9.0M | 4.99% | 317,003 | Common | SOLE |
| 351858105 | FNV | Franco Nev Corp | $7.9M | 4.39% | 32,000 | Common | SOLE |
| 784730103 | SSRM | SSR Mining In | $7.2M | 4.00% | 245,000 | Common | SOLE |
| 28657F103 | ELTX | Elicio Therapeutics Inc | $6.7M | 3.74% | 630,915 | Common | SOLE |
| M40527109 | ENTX | Entera Bio Ltd | $6.5M | 3.59% | 5,881,879 | Common | SOLE |
| 67080N101 | NUVB | Nuvation Bio Inc | $6.4M | 3.57% | 1,498,591 | Common | SOLE |
| 152006102 | CGAU | Centerra Gold Inc | $6.4M | 3.54% | 359,000 | Common | SOLE |
| 697900108 | PAAS | Pan American Silver | $5.5M | 3.03% | 100,035 | Common | SOLE |
| 85207K107 | PSLV | Sprott Physical silver Trust | $5.4M | 3.01% | 222,160 | Common | SOLE |
| 67576A100 | OCUL | Ocular Therapeutix Inc. | $5.1M | 2.82% | 600,400 | Common | SOLE |
| 89679M104 | TFPM | Triple Flag Precious Metals | $4.0M | 2.22% | 115,000 | Common | SOLE |
| 38071H106 | GROY | Gold RTY Corp | $3.6M | 1.99% | 1,000,000 | Common | SOLE |
| 011532108 | AGI | Alamos Gold Inc | $2.2M | 1.23% | 50,000 | Common | SOLE |
| 00289Y206 | ABEO | Abeona Therapeutics | $2.2M | 1.21% | 485,515 | Common | SOLE |
| 64782A107 | NEWP | New Pac Metals Corp | $2.0M | 1.11% | 485,000 | Common | SOLE |
| 192108504 | CDE | Coeur Mining Inc | $1.8M | 1.00% | 96,132 | Common | SOLE |
| 464288760 | ITA | iSHares US Aerospace & Defense | $1.7M | 0.93% | 7,650 | Common | SOLE |
| 718172109 | PM | Philip Morris Intl. Inc | $1.7M | 0.92% | 10,000 | Common | SOLE |
| 962879102 | WPM | Wheaton Precious Metals Corp | $1.6M | 0.91% | 12,500 | Common | SOLE |
| 666807102 | NOC | Northrop Grumman Corp | $1.5M | 0.82% | 2,165 | Common | SOLE |
| 099502106 | BAH | Booz Allen Hamilton HLDG COR | $1.0M | 0.56% | 13,000 | Common | SOLE |
| 28620K106 | ELE | Elemental RTY Corp | $943,000 | 0.52% | 50,000 | Common | SOLE |
| 92528V200 | VMET | Versamet Royalties Corp | $633,565 | 0.35% | 66,621 | Common | SOLE |
| 46655E100 | DC | Dakota Gold Corp | $620,751 | 0.34% | 122,921 | Common | SOLE |
| H2927K103 | AMRZ | Amrize LTD | $513,983 | 0.29% | 9,175 | Common | SOLE |
| 02155H200 | ALT | Altimmune Inc | $492,800 | 0.27% | 160,000 | Common | SOLE |
| 14161Y200 | CRDL | Cardiol Therapeutics Inc | $135,000 | 0.07% | 100,000 | Common | SOLE |
| 71716E105 | PHAR | Pharming Group NV | $67,508 | 0.04% | 4,057 | Common | SOLE |
| 68619K105 | — | Orgenesis, Inc. | $30,373 | 0.02% | 50,623 | Common | SOLE |
| 68390D106 | OR | OR Royalties | $8,555 | 0.00% | 225,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.